Literature DB >> 22886014

Streptozotocin-induced sporadic Alzheimer's disease: selection of appropriate dose.

Jogender Mehla1, Monika Pahuja, Yogendra Kumar Gupta.   

Abstract

The long term effect of single (day 1) and twice (day 1 and 3) injections of intracerebroventricular (ICV) streptozotocin (STZ) at the doses of 1 and 3 mg/kg on the cognitive functions of male Wistar rats was evaluated. Elevated plus maze, passive avoidance, and Morris water maze tests were used to assess the cognitive functions. A significant cognitive deficit was found at the 2nd week onwards, which persisted up to the 14th week with single and twice ICV-STZ (3 mg/kg) injections, whereas no cognitive impairment was found in ICV-STZ (1 mg/kg) treated groups after 8-10 weeks.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22886014     DOI: 10.3233/JAD-2012-120958

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

1.  Drotaverine Inhibitor of PDE4: Reverses the Streptozotocin Induced Alzheimer's Disease in Mice.

Authors:  Samra Nazir; Fareeha Anwar; Uzma Saleem; Bashir Ahmad; Zohaib Raza; Maham Sanawar; Artta Ur Rehman; Tariq Ismail
Journal:  Neurochem Res       Date:  2021-04-20       Impact factor: 3.996

2.  Long Acting Ionically Paired Embonate Based Nanocrystals of Donepezil for the Treatment of Alzheimer's Disease: a Proof of Concept Study.

Authors:  Naresh Mittapelly; Maharshi Thalla; Gitu Pandey; Venkatesh Teja Banala; Shweta Sharma; Abhishek Arya; Sandeep Mishra; Kalyan Mitra; Shubha Shukla; Prabhat Ranjan Mishra
Journal:  Pharm Res       Date:  2017-08-14       Impact factor: 4.200

3.  LX2343 alleviates cognitive impairments in AD model rats by inhibiting oxidative stress-induced neuronal apoptosis and tauopathy.

Authors:  Xiao-Dan Guo; Guang-Long Sun; Ting-Ting Zhou; Yi-Yang Wang; Xin Xu; Xiao-Fan Shi; Zhi-Yuan Zhu; Vatcharin Rukachaisirikul; Li-Hong Hu; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2017-06-26       Impact factor: 6.150

4.  Intranasal Insulin Enhances Intracerebroventricular Streptozotocin-Induced Decrease in Olfactory Discriminative Learning via Upregulation of Subventricular Zone-Olfactory Bulb Neurogenesis in the Rat Model.

Authors:  Sandeep K Mishra; Mahendra Hidau
Journal:  Mol Neurobiol       Date:  2020-10-29       Impact factor: 5.590

5.  Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer's type in rats.

Authors:  Dinesh K Dhull; Anil Kumar
Journal:  Inflammopharmacology       Date:  2017-12-16       Impact factor: 4.473

6.  Intracerebroventricular streptozotocin-induced Alzheimer's disease-like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex.

Authors:  Su-Ying Cui; Jin-Zhi Song; Xiang-Yu Cui; Xiao Hu; Yu-Nu Ma; Yu-Tong Shi; Ying Luo; Yan-Ru Ge; Hui Ding; Hui Ye; Yong-He Zhang
Journal:  CNS Neurosci Ther       Date:  2018-07-16       Impact factor: 5.243

7.  Intracerebroventricular streptozotocin induces impaired Barnes maze spatial memory and reduces astrocyte branching in the CA1 and CA3 hippocampal regions.

Authors:  María F Zappa Villar; Juliette López Hanotte; Eugenia Falomir Lockhart; Lucía S Trípodi; Gustavo R Morel; Paula C Reggiani
Journal:  J Neural Transm (Vienna)       Date:  2018-09-22       Impact factor: 3.575

8.  Intracerebral Injection of Streptozotocin to Model Alzheimer Disease in Rats.

Authors:  Daniel Moreira-Silva; Robson C L Vizin; Talita M S Martins; Tatiana L Ferreira; Maria C Almeida; Daniel C Carrettiero
Journal:  Bio Protoc       Date:  2019-10-20

9.  Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia.

Authors:  Mumin Alper Erdogan; Mehmet Kirazlar; Gurkan Yigitturk; Oytun Erbas
Journal:  Neurochem Res       Date:  2022-01-21       Impact factor: 3.996

Review 10.  Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.

Authors:  Chanchal Sharma; Sehwan Kim; Youngpyo Nam; Un Ju Jung; Sang Ryong Kim
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.